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Abstract 
Within the United States, it has been estimated that 60 deaths and 73,000 illnesses are 
caused by Escherichia coli O157:H7 infection annually (Gavin et al., 2004). Multiple effects 
have been known to occur with the onset of infection from E. coli O157:H7 in which some of 
these can become life-threatening.  Escherichia coli O157:H7 is defined as a Shiga-toxin-
producing E. coli strain (STEC).  This microbial pathogen is a gram-negative bacillus organism 
that is motile, non-sorbitol fermenting, and β-glucuronidase negative.  The infectious dose of E. 
coli O157:H7 can be as low as ten cells (Food and Drug Administration, 2009).  
 Consumption of contaminated food, mainly undercooked ground beef and non or 
incorrectly pasteurized milk, are the primary sources of E. coli O157:H7 infection in human.  
Cattle, in particular, are considered chief asymptomatic reservoirs for this pathogen.  Carried in 
their gut, feces, and milk, cattle carry this Shiga toxin-producing E. coli in ranges from 102 to 105 
CFU/g.  Although colonized with E. coli O157:H7, cattle and other ruminants show no adverse 
side effects from the pathogenic bacteria.  There is also a difference in the prevalence of this 
pathogen between human and cattle.  There has been a low incidence of illness caused by E. coli 
O157:H7 in humans when compared to the high prevalence of E. coli 057:H7 found in cattle and 
their environment.   
It has been discovered, through population genetic analysis, that E. coli O157:H7 and 
other O157:H- isolates make up a clone complex.  In spite of the clonal nature of E. coli 
O157:H7 and other O157:H- isolates, there are significant characteristics showing variability 
between  the clone complex. These variability aspects can possibly account for the rapid 
divergence of E. coli strains including the recently discovered divergence of E. coli O157:H7 in 
to two separate lineages.   Other possible reasons for a non-linear relationship between cattle 
prevalence and human infection include diversity of the Shiga Toxin-Encoding bacteriophage 
and receptors in cattle verses human, and finally the difference between the production of Locus 
of Enterocyte Effacement (LEE) in both human and cattle lineages. 
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CHAPTER 1 - Introduction of Escherichia coli O157:H7 
History and General Knowledge of Escherichia coli O157:H7 
In 1983, a microbial investigation was carried out by state health departments and the 
Centers for Disease Control and Prevention (CDC) to determine the cause of two hemorrhagic 
colitis outbreaks in 1982 in Michigan and Oregon.  Stool specimens were compared to the only 
isolate of Escherichia coli O157:H7, at the time, a rare strain of E. coli stored at the CDC in 
Atlanta that was recovered in 1975 from a woman with bloody diarrhea.  Matching the isolate 
from the CDC, it was confirmed that the stool samples contained E. coli O157:H7 (Tarr, 1995).  
In 1987, “Shiga-like toxin”, similar to that of Shiga toxin produced by Shigella, was discovered 
in E. coli O157:H7 isolates, which helped define its pathogenic ability. These toxic effects 
became more publically known after they were involved with the largest US E. coli O157:H7 
outbreak in 1993: Jack-in-the-Box outbreak. Increased screening for this pathogen in clinical 
laboratories has taken place and the US incidence of infection has risen remarkably since this 
outbreak.  According to the CDC (CDC, 2009), this lethal pathogen was also responsible for the 
following outbreaks: infected ground beef sold at Kroger in 2008, a multi-state outbreak in 
ground beef patties in 2006, Taco Bell outbreak in 2006, and a recent outbreak in raw Nestle 
cookie dough in 2009.  Throughout the decades, E. coli O157:H7 has caused numerous 
foodborne outbreaks and a rise in public concern due to its toxigenicity and repulsive effects in 
the human. Not only is E. coli O157:H7 now recognized as a common bacterial cause of bloody 
diarrhea, but also as the cause of Hemolytic Uremic Syndrome (HUS) in the United States, 
Europe and Canada (Besser et al., 1999).   
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Escherichia coli O157:H7 is defined as a Shiga-toxin-producing E. coli strain (STEC) 
and it has been suggested that this strain evolved from Enteropathogenic E. coli (EPEC) that 
acquired the Shiga toxin gene (Wachsmuth et al., 1997).  This pathogen is a Gram-negative 
bacillus that is motile, and differs from other E. coli in being non-sorbitol fermenting, and β-
glucuronidase negative.  However, E. coli O157 isolates that are non-motile, sorbitol fermenting, 
and β-glucuronidase positive have been isolated in Germany and Australia (Kaper and O'Brien, 
1998), but are rarely found in the United States.  Escherichia coli O157:H7 is a specific isolate 
of the bacteria, E. coli.  The O refers to the somatic antigen and the H refers to the flagellar 
antigen.  Part of this strains pathogenic ability derives from the 157st O antigen in combination 
with the 7th H antigen and it is these two antigens that are targeted when E. coli O157:H7 is 
screened for.  Possible signs of E. coli O157:H7 infection include, but are not limited to nausea, 
vomiting, slight fever, abdominal pain, HUS, thrombotic thrombocytopenic purpura (TTP), renal 
failure, lethargy, seizures, and coma (Su and Brandt, 1995).  
Disease in Humans and Sources of Infection 
In the United States, the most abundant amount of isolates have been recovered from 
Washington State, Oregon, Minnesota, and Massachusetts, suggesting that predominance of 
infections are in northern latitudes (Su and Brandt, 1995).  According to the Center for Science 
in the Public Interest Database (2009), predominance of E. coli O157:H7 infections from 1990-
2006 occurred in the contiguous northern states of North America (Fig. 1.1). Within the United 
States,  it has been estimated that 60 deaths and 73,000 illnesses are caused by E. coli O157:H7 
infection annually (Gavin et al., 2004). Multiple effects have been known to occur with the onset 
of infection from E. coli O157:H7 in which some of these can become life-threatening.  
Characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal failure, HUS 
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is a critical syndrome present in nearly 10 percent of children infected with E. coli O157:H7 
(Tarr, 1995).  HUS occurs predominately in young children and the elder and is the most 
common cause of acute renal failure in children.  Required dialysis is needed for roughly half of 
patients with HUS, while three-quarters require transfusions of erythrocytes or dialysis and 
approximately 15 percent of HUS patients suffer from chronic renal failure or death (Tarr et al., 
1989, Robson et al., 1991).   
In addition to HUS, central nervous system complications, including blindness, seizures, 
and mental retardation, can occur in 30-50 percent of patients infected with E. coli O157:H7 
(Cimolai et al., 1992) .  The case - fatality rate among nursing home residents can be as high as 
36 percent due to, in part, underlying diseases (Su and Brandt, 1995).  In a large former nursing 
home outbreak with E. coli O157:H7, 17 to 19 residents died due to hemorrhagic colitis, 
pneumonia, and HUS (Carter et al., 1987).   In non-life-threatening situations, individuals have 
been known to experience gastrointestinal complications, dehydration and severe abdominal pain 
due to bloody diarrhea.  Within 2 to 3 days medical care is usually sought with a majority of 
patients recovering within 10 days of the symptom’s onset (Riley et al., 1993).  
The infectious dose of E. coli O157:H7 can be as low as ten cells.  Consumption of 
contaminated food, mainly undercooked ground beef and non or incorrectly pasteurized milk, is 
the primary source of E. coli O157:H7 infection.  Cattle, in particular, are considered chief 
asymptomatic reservoirs for this pathogen.  Carried in their gut, feces, and milk, cattle can 
contain this Shiga toxin-producing E. coli in ranges from 102 to 105 CFU/g.  Ground meat should 
be cooked to 165°F in order to ensure that E. coli O157:H7 has been killed (USDA FSIS, 2006).  
In 1993, the largest outbreak of E. coli O157:H7 in the United States took place when 732 cases 
of illness, including 4 deaths of children, resulted from adulterated hamburgers provided by the 
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Jack-in-the-Box restaurant chain (Clark, 2005).  Although cattle are considered the main 
reservoir for this pathogen, a limited quantity of E. coli O157:H7 of bovine origin is associated 
with human infections.  Other common sources of infection include sheep, horses, dogs, wild 
birds, and houseflies (Ahmad and Zurek, 2006).  STEC-infected animals normally do not show 
signs of disease and, by law, can still be included in food production.  Consumption of this 
STEC- containing food has been identified as a major route of human infection in the United 
States as well as several other countries.  Ground beef is not the only path of transmission, but 
also juice, unpasteurized apple cider, ranch dressing, sandwiches, and many other meats 
including salami and roast beef (Fig. 1.2).  Fruits and vegetables have recently been reported to 
have E. coli O157:H7 causing an increase in the number of outbreaks.  In 2006, a multistate 
outbreak of E. coli O157:H7 swept through spinach fields in which the spinach was later bagged 
and transported to grocery stores for consumer consumption.  There were 205 confirmed 
illnesses from this outbreak including 3 deaths and 105 hospitalizations in which 30 percent of 
these patients developed HUS (California Food Emergency Response Team, 2007).   
Escherichia coli O157:H7 has been able to enter the human population in various ways as 
shown by Figure 1.3.  Besides contaminated food, E. coli O157:H7 has been isolated from wild 
animal feces and the environment (Beutin et al., 2007).  Untreated recreational waters, such as 
lakes, are often populated with this pathogen due to contaminated animals feces entering the 
body of water.  Individuals may swim in contaminated lakes and unknowingly become infected 
and possibly become a reservoir by person to person contact.    
Highly resistant to physiochemical stresses, STEC strains are capable of living in acidic 
conditions as well as dryness.  Surviving long periods of time in soil, manure, and water are also 
characteristics of this hardy pathogen.  Not only is E. coli O157:H7 resistant to stress, but also to 
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antibiotics.  Recently, it has been demonstrated that E. coli O157:H7 has become increasingly 
more resistant to streptomycin, sulfisoxazole, and tetracycline, possibly as a result of the 
prevalence of this organism in food animals that receive these antibiotics (Besser et al., 1999).  
Even though antibiotics relieve mild symptoms, there has not yet been an effective treatment in 
reducing HUS or the Shiga toxin-producing virulence factor emitted by E. coli O157:H7. 
Virulence Factors of Escherichia coli O157:H7 
The Shiga like toxin-producing element is the defining characteristic of STEC.  Shiga 
toxins were first classified in Shigella dysenteriae and has became a part of an E. coli isolate 
after contacts between the two organisms. The life-threatening complications that result from E. 
coli O157:H7 infections are based on the production of virulence factors, Shiga toxin I (stx1) and 
Shiga toxin II (stx2).  Shiga toxin is comprised of two subunits, AB5 (Fig. 1.4). The A subunit is 
responsible for causing the toxic effect of the protein, while 5 similar B subunits all work 
together to bind to receptors on target cells (Cherla et al., 2003).  Based on epidemiological data, 
isolates that produce stx2 alone are more likely to cause severe disease compared to isolates that 
produce only stx1 or the combination of stx1 and stx2, although, the latter two are capable of 
producing disease.  Evidence that stx1 causes severe STEC infection comes from multiple animal 
studies.  For example, after administered stx1, intravenously, baboons produced clinical 
symptoms of HUS (Ritchie et al., 2003).  
The virulence of E. coli O157:H7 is partly based on the prophage encoded Shiga toxin 
within the bacterium. Bloody diarrhea and abdominal cramps result from E. coli O157:H7 
infections and are often initiated when endothelial cells in the digestive tract or kidneys are 
destroyed by the toxin.  The severity of STEC infections correlate to the amount of bacterium 
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ingested and the amount of Shiga toxin produced.  Unfortunately, low quantities of each can 
initiate an E. coli O157:H7 infection in humans.     
Shiga toxin is not the only virulent factor in STEC.  Intimin is a major concern as this is 
the adhesion molecule responsible for attachment of STEC organisms to the epithelial cells of 
the intestine, which can cause structural modifications and lesions.  Finally, a third virulent 
factor in STEC organisms are called Locus for Enterocyte Effacement (LEE), which is a cluster 
of genes that encode various virulent factors making the organism pathogenic.  One of these 
genes is the eae gene which is responsible for encoding the adhesion molecule, intimin.  It is 
purposed that these three specific virulence factors work together to produce the pathogenic 
effects E. coli O157:H7 (Boerlin et al., 1999). 
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Figures and Tables 
Figure1.1 Map representing number of Escherichia coli O157:H7 cases during 1990-2006. 
(Multistate outbreaks are not included in the numbers shown). 
 
Figure 1.2 Percentages of Escherichia coli O157:H7 outbreaks based on contaminated food 
 sources.  
     
                     (Center of Science in the Public Interest Outbreak Database, 2009). 
(Center of Science in the Public Interest outbreak database, 2009) 
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Figure 1.3 Possible routes of how Escherichia coli O157:H7 can enter the human population. 
 
          (Page, 2009) 
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Figure 1.4 (A) General structure of an AB5 toxin molecule. (B) The A subunit of the Shiga-toxin. 
(C) The B subunit from Shiga-toxin.  
 
 
 
 
 
 
 
 
 
 
 
             (Merrit and Hol, 1995) 
       (Paton et al., 2006)              (Byres et al., 2008) 
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CHAPTER 2 - The Presence and Prevalence of Escherichia coli 
O157:H7 in Cattle 
Escherichia coli O157:H7 was introduced into the cattle population by the means of feed.  
Grain- fed cattle seem to have a significantly higher level of E. coli O157:H7 compared to grass-
fed cattle.  A grain diet turns a cattle’s rumen into an ideal habitat for E. coli O157:H7 while the 
lethal strain of E. coli cannot survive for long periods of time on a grass fed rumen. Not only is 
there an increased number of E. coli O157:H7 in rumens of grain-fed cattle, but also in the tons 
of manure they produce each year.  Approximately a billion tons of contaminated manure is 
produced, by agricultural animals, each year and often ends up in locations other than pastures, 
causing bacteria to travel to other habitats, animals, and environmental resources. Ultimately, 
this brings the pathogen closer to humans and finished food products with a chance of increasing 
infection rates in the human population (Pollan, 2006).          
Several foodborne illnesses in humans result from the consumption of food products that 
are contaminated with pathogenic bacteria.  Products can be contaminated via poor water 
sources, environmental agents, or other suitable hosts such as animals and insects. Even though 
safety policies such as HACCP (Hazard Analysis and Critical Control Points) and GMP’s (Good 
Manufacturing Practices) have been put into effect, cattle have been identified as the primary 
source of E. coli O157:H7 in the United States.   Escherichia coli O157:H7 is transmitted to 
human by the cattle in various ways including: contaminated cattle hide, the cattle’s natural 
environment, drinking water, shedding of feces, agricultural fairs, and through cross 
contamination in the slaughter process.  Seasons can have an influential effect on the prevalence 
of E. coli O157:H7 isolated from cattle.   
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It has been suggested by Omisakin et al. (2003) that the concentration of E. coli O157:H7 
in ruminant feces increases during warmer months of the year, and this fluctuation of bacteria, 
during winter to summer months, can range anywhere from 103 to 105 CFU per gram of feces.  
The most common range of E. coli O157:H7 being shed, during summer months, is 
approximately 103 CFU/g.  However, a small proportion of cattle will shed amounts between 103 
CFU/g and 105 CFU/g and this specific group is referred to as “super shedders”.  This group 
causes the most concern as they can contribute the most bacteria to carcasses and meat products 
(Omisakin et al., 2003).   
The average test shows that E. coli O157:H7 prevalence, in a single herd, can be as high 
as 10 percent and in the overall beef cattle population the prevalence can be as high as 28 
percent.  The prevalence approximations may be slighter lower than actual prevalence data due 
to not enough herds tested, not enough animals within the herds tested, tests with low sensitivity, 
and seasonal variation during test times (Grauke et al., 2002).  Although colonized with E. coli 
O157:H7, cattle and other ruminants show no adverse side effects from the pathogenic bacteria. 
The Shiga toxin receptor, needed to cause illness, has not been found in cattle and the absence 
presents a possible reason for the differing effects between cattle and human (Pruimboom-Brees 
et al., 2000). 
A study conducted by Cambridge University (Hancock et al., 1994) tested the prevalence 
of E. coli O157:H7 in dairy cattle and beef cattle in Washington State.  Sixty dairy herds were 
tested by taking samples of fecal material along with samples of bulk milk.  Twenty-five beef 
cattle herds were tested by taking samples from the cattle hide and fecal deposits.  It was 
concluded that 10 of the 3570 samples in dairy cattle were positive for E. coli O157:H7.  Seven 
of the 10 positive samples were obtained from calves. The 10 positive samples were from 5 of 
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the 60 herds tested.  Ten of the 1412 beef cattle fecal samples contained positive results of E. coli 
O157:H7.  The 10 positive samples came from 4 of the 25 herds tested.  All screening for E. coli 
O157:H7 in milk samples returned negative results.   It can be suggested that beef cattle have a 
higher prevalence of E. coli O157:H7 based on the 0.7% prevalence compared to dairy cattle that 
retained 0.28% prevalence.  Dairy cattle had E. coli O157:H7 in 8.3% of the herds tested, while 
beef cattle had the bacteria in 16% of herds tested (Hancock et al., 1994).   
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CHAPTER 3 - Proposed Reasons for High Prevalence of Escherichia 
coli O157:H7 in Cattle, but Low Incidence of Pathogenic Illnesses in 
Humans from Similar Strains. 
Diversity among Conserved Genomic Regions in Human and Bovine Strains 
of Escherichia Coli O157:H7 
In the many years given E. coli O157:H7 has been in existence, it has taken thousands of 
lives (CDC, 2009), caused thousands of foodborne illnesses and outbreaks (CDC, 2009), and has 
drawn a large amount of attention from the public, CDC and other governmental agencies such 
as the USDA and FDA(CDC, 2009).  Pathogenic effects in the human are not apparent in the 
main reservoir, cattle, that serves the human population (Pruimboom-Brees et al., 2000).  Not 
only is there a difference in the effect between human and cattle when it comes to this pathogen, 
but also in the prevalence of this pathogen within the human and cattle populations.  There has 
been a low incidence of illness caused by E. coli O157:H7 in humans when compared to the high 
prevalence of E. coli 0157:H7 found in cattle and their environment.  Research, independent 
studies, experiments, and analysis of clinical cases have been done in order to determine why the 
properties of E. coli O157:H7 differ greatly among humans and cattle (Besser et al., 2006, Kim 
et al., 1999, Pruimboom-Brees et al., 2000, Steele et al., 2007.)   The genomic difference 
between E. coli O157:H7 strains have been a possible answer to why cattle prevalence and 
incidence of human illness has not share a linear relationship. Other possible reasons include 
diversity of Shiga toxin production and receptors in cattle verses human (Besser et al., 2006), the 
difference between the production of Locus of Enterocyte Effacement (LEE) in both human and 
cattle lineages (McNally et al., 2001), and the Q933 gene involvement (Ahmad and Zurek, 
2006).  
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It has been discovered, through population genetic analysis, that E. coli O157:H7 and 
other O157:H- isolates make up a clone complex.  In spite of the clonal nature of E. coli 
O157:H7 and other O157:H- isolates, significant characteristics showing variability between the 
clone complex has been observed through various genomic typing methods, such as pulsed field 
gel electrophoresis (PFGE) and octamer-based genome scanning (OBGS).  These variability 
aspects can possibly account for the rapid divergence of E. coli strains including the recently 
discovered divergence of E. coli O157:H7.  By the means of OBGS, it has been suggested that E. 
coli O157:H7 has diverged in to two separate lineages, lineage I and lineage II.  Lineage I has 
been known to populate the human species whereas lineage II has appeared more in cattle.   
The discovery of two separate lineages was in 1999 and has been followed by a cascade 
of research studies supporting its finding (Kim et al., 1999, Steele et al., 2007).  Octamer Based 
Genome Scanning was the method used to determine the genetic diversity among human and 
bovine isolates of E. coli O157:H7.  Human and bovine isolates of E. coli O157:H7 were found 
to be non-randomly distributed among the two lineages after analysis of OBGS products.  The 
segregation of isolates has suggested that one of these lineages could be less virulent for humans 
or may not have the ability to be transmitted to humans by bovine sources (Kim et al., 1999).  
The transmission uncertainty of isolates between human and bovine species could relate to the 
high prevalence of E. coli O157:H7 in cattle, but low incidence of infection in humans 
comparatively. 
Developed recently, was the lineage-specific polymorphism assay (LSPA-6) which is 
based on six loci that show bias in their allelic distribution between the two lineages.  A study 
conducted by Steele et al. (2006) which used LSPA-6 strain and utilized the suppression 
subtractive hybridization (SSH) method to identify genomic regions present in E. coli O157:H7 
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lineage I strains but absent from the lineage II strains.  The lineage I strains used in the study 
were LSPA-6 111111 and the lineage II strains were LSPA-6 222222.  After identifying genomic 
regions of difference (RDI), (genomic sequences that were present in the lineage I strain, but 
absent in the lineage II strain) the study then identified conserved regions of genomic difference 
(CRD).  These were candidates that were conserved across multiple lineage I strains and absent 
in multiple lineage II strains (Fig. 3.1).  After the genomic regions were determined, it was noted 
that lineage 1 strains share a set of unique genes that are largely absent in lineage II strains.  The 
exact contributions of these genes are unknown, but they are thought to be responsible for 
expression of virulence factors in lineage I strains (Steele et al., 2007).   
Many studies have played a role in trying to determine the cause of the pathogenicity of 
E. coli O157:H7 and differences between humans and bovine isolate, while the findings of new 
lineages has been a big step.  
Variety among Shiga Toxin Receptors in Human vs. Bovine Strains of 
Escherichia coli O157:H7 
Shiga toxin refers to a family of toxins that is subdivided into two groups, Shiga toxin 1 
(stx1) and Shiga toxin 2 (stx2).  This toxin is of Shigella dysenteriae bacterium origin and was 
first described by Kiyoshi Shiga (Beutin, 2006).  Two of the most common sources of Shiga 
toxin production has been Shigella dysenteriae and the Shigatoxigenic group of Escherichia coli 
(STEC).  Shiga toxin is one of the main virulence factors produced in STEC.   
The action of Shiga toxin has been associated with HUS and hemorrhagic colitis (HC) in 
multiple patients who have tested positive for E. coli O157:H7.  Since the toxin is not 
recognizable to the human’s immune system, and once the Shiga toxin is released from the 
STEC organism, the body’s natural response is to increase permeability of cell barriers so 
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neutrophils and polymorphonuclear leukocytes (PMN) can reach the infection. PMN’s are white 
blood cells, varying in nucleus size and shape from each other, that are responsible for attacking 
foreign objects in the body (American Heritage® Medical Dictionary, 2007).  Using this 
opportunity, the toxin breaks through cell walls of the digestive tract, continuing through the 
Golgi apparatus to the Endoplasmic Reticulum (ER) and nuclear membrane, and then enters the 
blood stream and translocates to other organs such as the central nervous system and kidneys 
(Pritzker, 2006). This intracellular method of trafficking is referred to as retrograde transport (see 
Fig 3.2).   
Shiga toxin is considered a 6-compenent protein structure, AB5.  The B subunit is 
responsible for attaching to target cell receptors, specifically globotriaosylceramide (Gb3), while 
the A subunit is internalized and cleaved into A1 and its other components.  A1 travels to the 
cytoplasm where it cleaves an amino acid from the 60S ribosomal subunit in the target cell.  This 
action prevents t-RNA binding and therefore disrupts protein synthesis.  With incoherent 
synthesis of required proteins, functions of targeted cells seize and cell death occurs.   Cell death, 
by apoptosis, does not occur in all cell types, but there is sufficient information suggesting that 
vascular lesions and tissue damage can result from apoptosis and could be the precursor to severe 
disease.  The toxin is highly specific for the Gb3 receptor on cell surfaces in order for the B 
subunit to attach and the A subunit to enter the cell and for severe disease to result (Pritzker, 
2006). 
Certain animals, such as cattle, deer and swine do not contain this specific receptor on 
some cells which is a potential answer to why cattle have been a reservoir for E. coli O157:H7, 
but have not been affected by its pathogenic effects, as in humans. Bovine do however contain 
this receptor on their crypt intestinal epithelial cells, but escape cell death by rerouting the toxins 
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to lysosomes instead of the ER where they come into contact with ribosome’s (Cherla et al., 
2003). The bacterium is then shed through bovine feces where it can come into contact with the 
human population causing illnesses and outbreaks.  A study performed by Pruimboom-brees et 
al., (2000) revealed that cattle lack the vascular receptor, Gb3, for E. coli O157:H7 Shiga toxins.  
In contrast to humans in which severe disease results from stx production, E. coli O157:H7-
infected cattle are tolerant of the pathogen and remain disease free for most of their lives.  On the 
other hand, newborn calves are affected by E. coli O157:H7 and suffer from fatal ileocolitis.  It is 
unknown as to why calves are susceptible to E. coli O157:H7 induced disease, but are tolerant 
carriers of the pathogen as adults.  Within the study two suggestions were made: Cattle lack 
receptors for stx, and newborn calves have receptors for stx, but they disappear with age.   The 
hypothesis resulted after examination of glycolipid levels in various tissue including kidneys, 
ileum, rectum, brainstem and cerebrum of newborn calves.  It was determined that high levels of 
Gb3 receptors were present in samples from the kidney, brainstem and cerebrum while there was 
an undetectable amount in the ileum and rectum.  Undetectable amounts of Gb3 were present in 
all tissues from adult cattle tissue tested.  The research supports the idea that adult cattle do not 
contain Gb3 receptors and as a result do not experience E. coli O157:H7 induced disease as do 
humans. Calves have given a new insight to Gb3 research and have provided knowledge of how 
receptor concentrations differ among species and age (Pruimboom-Brees et al., 2000).   
Shiga toxin 2 has been found to be up to 400 times more toxic, in regards to HUS related 
illnesses, than Shiga toxin 1.  A study was carried out in 2008 that tested for the presence of stx2 
in various cells.  Mice were given stx2 and no stx1, intraperitoneally, which resulted in weight 
loss, paralysis and death.  Examination of mice, after death, showed an increase in Ca+ flux 
within the cerebral, which suggested that there was an increased neurotransmitter release from 
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neurons caused by the toxin. Since neurons contain a high level of Gb3 receptors, it has been 
suggested that neurons are a main target sight for Shiga toxin and its close relative Shiga-like 
toxin.  Gb3 is more frequently found, for unknown reasons, within renal epithelial cells, and 
central nervous system neurons and endothelium which is a possible factor for neurotoxicity 
resulting from E. coli O157:H7 illness (Obata et al., 2008).   
A previous study conducted (Boerlin et al., 1999) was subject to determine the 
associations between virulence factors and STEC disease in humans. Another aim was to 
compare bovine and human STEC populations of major serotypes involved in human disease.   A 
major finding in the study was discovered through multivariate analysis of five virulence factors:  
EHEC hemolysin (ehxA), a Protease (espP), intimin encoding gene (eae), stx1 and stx2 encoding 
genes.   Multivariate analysis is a method of research that involves analysis of more than one 
factor at a time instead of focusing on one factor during the study.  After investigation of all five 
virulence factors, only the eae and stx2 genes had a significant relationship.  This supports the 
ongoing hypothesis of synergism among the adhesion intimin molecule and Shiga toxin 2 
production.  The second aim, using univariate analysis, determined that eae and stx2 were 
significantly more common in serotypes found in humans when compared to bovine strains.  The 
opposite was found true for stx1. Shiga toxin 1 was more frequently isolated from serotypes not 
found in humans than those associated with humans (Boerlin et al., 1999).  This study agrees 
with previous studies showing eae and stx2 are more frequent in STEC isolates causing severe 
disease and stx1 as being more frequent in some STEC isolates of bovine origin (Table 3.1).  
Multiple studies have studied the effects of the individual virulent factors and the specific aspects 
of each one. However, the study conducted by Boerlin et al. (1999) presents the idea that there is 
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no single factor responsible for the virulent effects produced by STEC and instead that multiple 
factors work together to produce the pathogenic outcome of E. coli O157:H7 
Reported by Schmidt et al. (1995), the new genetically analyzed ehxA, has been 
associated with severe clinical disease in humans.   Boerlin’s previous study (1999) shows a high 
prevalence in ehxA and eae in STEC isolates regardless of disease severity.  However, the strong 
relationship with eae suggests that ehxA is likely to assist in disease as previously suggested by 
Schmidt (Boerlin et al., 1999) (Fig 3.3).  Shiga toxin has been capable of producing illness in 
humans, but not in cattle.  This outcome is only partly due to the toxin being released.  Besides 
the toxin, other virulent factors such as genetic sequences, intimin, LEE, and the Q933 gene all 
have a responsibility to the disease-causing component of E. coli O157:H7 and other EHEC 
organisms. 
Even though genetic sequences, directly, are not virulent they can be the cause of virulent 
actions.  Some virulence genes, such as stx1, are often regulated by iron concentration.  In a 
study conducted in 2007, it was determined that E. coli O157:H7 contains a cluster of Open 
reading frames (ORF) within a Conserved Region of Difference in Lineage I  (CRDI), specific to 
lineage I that may represent an iron uptake system. This could be responsible for triggering stx1 
gene to continue on with virulent action (Steele et al., 2007). 
The Role of Intimin in Escherichia coli O157:H7 
Intimin is a vital aspect in relation to both Shiga toxin production and severe disease in 
humans.  Intimin is an adhesion virulence factor in EHEC E. coli strains.  It is found on the cell 
surfaces and is considered an attaching and effacing (A/E) protein.  It can bind to its receptor, 
Tir, which is secreted from bacterial cells into the host cytoplasm of intestinal epithelial cells by 
means of Type three Secretion System (TTSS).  TTSS is an organelle found mostly in Gram 
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negative bacteria pathogenic bacteria and is used to secret proteins to help the bacteria infect 
eukaryotic organisms (Salmond and Reeves, 1993).   
 A study performed by Cookson and Woodward (1992) tested for the role of intimin, for 
adherence, in E. coli O157:H7 strains.   To carry out the study, the eae gene was inactivated in 
three strains of E. coli O157:H7 from various origins.  Adherence of intimin to epithelial cells 
showed no intimate adherence, whereas wild type E. coli O157:H7 strains showed a high amount 
of adherence.  Adherence in wild type E. coli O157:H7 was determined by findings of A/E 
lesions and colonies on cells.  The study also looked into intimin-independent adherence using 
neonatal calf gut explants. The same wild type and mutant strains from the first part were used to 
compare adherence in colon tissue and rumen tissue in the neonatal calves.  It was found that the 
same amount of adherence took place whether the calf was given wild type or the eae-inactivated 
version of E. coli O157:H7.   The studies’ outcome confirms that intimin does play a strong role 
in adherence between E. coli O157:H7 and various cells, but also that there could possibly be 
another factor contributing to bacterial adherence causing pathogenic illness (Cookson and 
Woodward, 2002).  
 Variants of the intimin molecule differ between bacterial isolates.  The diversity of 
intimin subtypes across a diverse collection of E. coli O157:H7 from both bovine and human 
origin was examined.  The basis of the study was to use Polymerase Chain Reactions (PCR) to 
amplify the C-terminal amino acids in the bacteria and then utilize restriction fragment length 
polymorphism (RFLP) analysis to differentiate the subtypes.  By utilizing this method, three new 
subtypes of intimin were found. The origins of the new subtypes were not of importance in the 
study, but instead the subtype sequences.  The study shows that there are undiscovered intimin 
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receptors and that they could be a reason for the difference between adhesion activity within 
pathogenic bacterial strains (Ramachandran et al., 2003). 
Anti-Terminator Q933 Gene Involvement in Escherichia coli O157:H7 
Virulence 
Although ruminants appear to be the obvious reservoir for E. coli O157:H7, bovine 
serotypes are not frequently isolated from human patients.  Part of the reason for this mystery 
could be due to the Q933 gene within the E. coli genome.  The stx2 gene, which is regulated by 
the interaction between the PR’ and Anti-Terminator Q gene, is located upstream of Anti-
Terminator Q.  Anti-Terminator Q initiates the late promoter, PR’, and in doing so transcribes the 
stx gene furthering Shiga toxin production.  In a study by Ahmad and Zureck (2006), it was 
proposed that isolates with Q933 produced significantly more Shiga toxin compared to isolates not 
containing Q933.  The study consisted of 262 environmental strains of E. coli O157:H7 which 
were isolated from beef cattle feces and housefly digestive tracts. All strains were screened for 
Q933 and Q21 (anti-terminator Q21 of bacteriophage 21).  It was found that only 3.4% tested 
positive for Q933, while 61.5% tested positive for Q21, and 25.1% carried both Q alleles. Even 
though a minimal percent of the tested strains were positive for Q933 alone, it was these strains 
that had the highest Shiga toxin production.  They produced higher amounts of Shiga toxin 
compared to strains that contained Q21 alone or the combination of Q alleles. These conclusions 
suggest that Q933 could be an important factor in clinically relevant strains since humans can be 
subjected to large amounts of Shiga toxin when infected with E. coli O157:H7 (Ahmad and 
Zureck, 2006).   
It has been demonstrated that the anti-terminator Q933 is more common in human isolates 
than cattle isolates of E. coli O157:H7.  It was also demonstrated that geographical regions that 
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have low E. coli O157:H7 illnesses also have a low number of E. coli O157:H7 isolates 
containing Q933 (LeJeune et al., 2004).  In the study by LeJeune et al. (2004) 158 E.coli O157:H7 
isolates were analyzed for Q933 and Q21.  Ninety-one isolates were of bovine origin and 67 were 
originally isolated from ill persons. Pulse Field Gel Electrophoresis and Enzyme-linked Immune 
Sorbent Assay (ELISA) was done on each strain to gather conclusions. It was determined that the 
human strains contained Q933 while the bovine strains contained the Q21 gene.  Nine strains of the 
158 strains initially tested were known to be of lineage I genotype and seven were of lineage II 
genotype. Lineage I E. coli O157:H7 strains are known to be more frequently isolated from 
humans than cattle.   The study found that the lineage I strains contained the Q933 gene whereas 
the lineage II strains, which are more frequent in cattle, contained the Q21 gene and not the Q933 
gene (Fig. 3.4). This could help explain why lineage I strains tend to produce Shiga toxin in 
higher amounts compared to lineage II strains (LeJeune et al., 2004).   
The presence of Q933 is higher in human isolates than cattle isolates, and its presence 
corresponds to a higher Shiga toxin production than Q21.  This could relate to why cattle can 
carry E. coli O157:H7 isolates, but are asymptomatic: Cattle may simply not have E. coli 
O157:H7 isolates that contain the Q933 gene.      
Locus of Enterocyte Effacement  
The locus of enterocyte effacement (LEE) is a pathogenicity island, within the EHEC 
bacteria, which is clustered with genes that encode multiple virulent factors.  Such genes include 
ones that encode intimin (eae), intimin’s receptor (Tir), Shiga toxins (stx1 and stx2), EHEC 
hemolysin (ehxA), and the LEE effector molecules (espA, espB and espD).   Eae and Tir have 
played a crucial role in formation of A/E lesions in several cell culture models and are expected 
to work simultaneously within bovine and human environments as well.  EhxA is also known to 
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contribute to severe disease in humans infected with EHEC (Ritchie et al., 2003).  Many studies 
have looked into the effects of the individual LEE encoded factors, but have not studied the 
combined effects or ratios of LEE factors in both human and bovine populations. 
Recent epidemiological data has shown a high prevalence of E. coli O157:H7 in cattle 
and their environment, but a relatively low level of infection in humans.  A common suggestion 
to why this has occurred promotes the pathogenic differences between human and cattle.  A 
study performed in 2001 has tried to explain the contradicting high E. coli O157:H7 cattle 
prevalence and the low human disease incidence from E. coli O157:H7.  A range of virulence 
determinants, including toxins and adhesions, were screened from human disease and bovine 
fecal E. coli O157:H7 strains.  Factors were examined in relation to each other.  Secreted protein 
profiles and actin rearrangement was investigated to note the difference between the human and 
bovine strains.  Results showed a significant strain and medium dependent variation in espD and 
Tir secretion levels.  The higher secretion rate of espD in different media suggests different ways 
LEE can react between different environments such as the human and bovine atmospheres.  Esp 
secretion in general correlated to the amount of lesions present during examination of tissue 
culture.  Strains of human origin produced considerably higher levels of espD than the majority 
of strains from bovine origin, which illustrated the human pathogenic potential in which bovine 
do not posses.  The overall study has suggested that not only do human strains have increased 
stx1 and stx2 compared to the bovine population, but also a greater secretion and expression of 
other LEE-encoded factors (McNally et al., 2001). 
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Figures and Tables 
Table 3.1 Distribution of virulence factors from bovine and human STEC serotypes. The 
numbers in the columns represent the number of isolates tested for the specified gene.  The 
number in parentheses represent of the total category positive for that specific gene.  The 
serotypes were analyzed for 5 major genes in both bovine and human isolates.  Serotypes used 
were: O26:H11, O103:H2, O111:H8, O111:H-, O145:H-, and O157:H7 
  
 
         (Boerlin et al., 1999) 
 
Figure 3.1 Depiction of conserved genetic regions through multiple lineage I strains and their 
absence in lineage II strains of Escherichia coli O157:H7. 
                    (Page, 2009) 
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Figure 3.2 Model of disease pathway concerning Escherichia coli O157:H7 and Shiga-toxin. 
                                                  (Pritzker, 2006) 
 
Figure 3.3 (A) Diagram representing the indirect relationship between the EHEC hemolysin 
molecule and disease in humans. (B) Diagram representing the direct relationship between the 
EHEC hemolysin molecule and disease occurrence in humans.                      
 
                  (Boerlin et al., 1999) 
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Figure 3.4 PCR products of human verses bovine strains of Escherichia. coli O157:H7 and 
whether or not they contain Q933 gene. EDL933 (human-origin) shows Q933 gene.  FAHRP88 
(bovine-origin) does not contain the Q933 gene).  
     
                                     (LeJeune et al., 2004) 
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CHAPTER 4 - The Effects of Escherichia coli O157:H7 on the 
human population: Case Studies 
A multistate outbreak of E. coli O157:H7 during December and November of 2000 led 
the USDA FSIS to announce a class 1 recall on ground beef.  A Green Bay, Wisconsin meat 
plant voluntarily recalled 1.1 million pounds of ground beef that had been distributed to 15 
different states.  The Wisconsin Division of Public Health (WDPH), along with local health 
departments, and the Wisconsin State laboratory of Hygiene  (WSLH) conducted an in-depth 
investigation which involved reported E. coli O157:H7 cases, isolated strains of E. coli O157:H7 
and interviews to all suspected cases of E. coli O157:H7.  In a press release from the WDPH, 
symptoms and sign of infection were made clear to the public and symptomatic persons were 
urged to attend their local health department for medical attention and submission of a stool 
sample to identify possible E. coli strains. Possible E. coli O157:H7 infections were reported to 
the WDPH from local health agencies while all E. coli O157:H7 isolates from specimen were 
forwarded to the WSLH for further confirmation using standard methods recommended by the 
Centers of Disease Control and Prevention (CDC).  Pulse field gel electrophoresis (PFGE) along 
with traditional agar methods were utilized to receive the most accurate results.  During the 
investigation, 74 laboratory- confirmed cases of E. coli O157:H7 were reported from the WDPH.  
The patient age ranged from 3 to 84 including six hospitalizations and one case of HUS.  After 
further investigation of E. coli O157:H7 isolates, it was concluded that there was a total of four 
different patient strains of E. coli O157:H7 involved in the outbreak (Proctor et al., 2002).  This 
study gives us insight as to how many various strains can reside within cattle populations 
compared to the number of strains that cause disease in humans.  The difference in strains could 
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explain the difference in symptoms among people and the severity of diseases ranging from 
diarrhea to HUS.   
Escherichia coli O157:H7 has not only been passed from cattle to human by means of 
food products.  Physical contact between human and cattle and their environment has been a 
substantial risk of E. coli infection if proper measures regarding safety and cleanliness were not 
considered.  In October 2004 one of the largest petting zoo outbreaks of E. coli O157:H7 
occurred during the North Carolina State Fair.  After three HUS infections were reported in the 
state, the North Carolina State Laboratory for Public Health and the US department of 
Agriculture conducted an investigation to find the source of the Shiga-toxin-induced HUS 
infections.  96 initial environmental samples were taken from fair grounds including: animal 
bedding, manure from animal sites, swabs from floors and fans, swabs from apple cider presses, 
water samples from fountains, and live flies in animal exhibits.  Between October 8 and 
November 12, 2004 there were 108 outbreak related cases. 43 of these cases were laboratory-
confirmed E. coli O157:H7 infections and overall 15 cases of HUS were reported (Fig. 4.1).  The 
median age was 5.4 years suggesting that mouth-to-hand activities, such as thumb sucking, and 
eye rubbing could have been the means of bacterial transfer between the state fair and humans.  
The environmental sampling did not support hypothesis of food or water borne transmission. It 
was concluded that 1 of the 2 petting zoo locations within the state fair was consistently 
contaminated with E. coli O157:H7.  This location was of popularity as it was an area where 
visitors could directly interact with approximately 100 sheep and goats. Some live stock exhibits 
had slight STEC O157 contamination, but was thought to spread from the same petting zoo 
location that possessed high numbers of E. coli O157:H7 when investigated (Goode et al., 2009).  
This case study shows how education is important for protection against bacterial transmission.  
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Products such as hand sanitizers have increased awareness and healthy habits, but is not always 
utilized which can produce a cascade of person to person transmission. 
In 1993, a large E. coli O157:H7 outbreak occurred in California due to undercooked 
meat and hamburger patties distributed by the national food chain, Jack-in-the-Box.  People 
became sick in multiple states, from multiple locations of this chain, including Seattle, Idaho and 
Nevada.  Overall, four children died due to HUS and over 600 became ill.  After investigation it 
was discovered that the ground beef patties were actually contaminated with fecal material 
causing the severe illnesses in people.  It was known as the largest E. coli O157:H7 outbreak in 
America up to that time (Department of Defense, 1993).  This shows how improper safety 
measures can effect food products and put millions of people at risk. Since then, numerous safety 
precautions have been made, such as HACCP and GMP’s to help prevent foodborne illnesses 
and hinder bacteria from transmission. 
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Figures and Tables 
 
Figure 4.1 Dates of illness onset due to Shiga-toxin producing E. coli outbreak, from North 
Carolina State Fair, in 2004.  
                                             (Goode et al., 2009) 
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CHAPTER 5 - The Importance of High Escherichia coli O157:H7 
Prevalence in Cattle in Regards to the Relatively low Incidence of 
Escherichia coli O157:H7-Induced Disease in Humans 
Multiple studies have supported the idea that E. coli O157:H7 colonizes in high 
prevalence within wildlife animals with cattle being the main reservoir.  On the other hand, 
incidences of disease in humans remain relatively low even with the low infectious dose of the 
organism. It is important to understand this relationship to help monitor what strains are capable 
of transmission between cattle and human populations.  Different E. coli O157:H7 isolates 
contain different pathogenic potentials and thus are not always capable of transfer between 
species.  If the prevalence of various strains is known, then being able to monitor those strains in 
humans could give insight to the simplicity of transmission for specific isolates.   
 There are major differences among Shiga-toxin production, virulent factors, LEE 
and genetic sequencing regarding strains of E. coli that effect humans yet do not promote effects 
in cattle.   This supports the findings of Kim et al. (1999) proposing two different lineages of E. 
coli O157:H7.  Perhaps the prevalence in cattle includes many isolates of E. coli O157:H7, while 
only a few of those are capable of producing pathogenic effects in humans due to the numerous 
pathogenic differences among strains. 
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CHAPTER 6 - Possible Areas of Future Research 
Genetic analysis of E. coli O157:H7 and its lineages could potentially give more answers 
to why the bacteria is so prevalent in cattle yet has such little incidence of infection in human, 
comparatively.  It was determined that iron uptake could trigger stx1.  If this is the case, then 
perhaps research concerning bovine and human iron intake could become another area of 
interest.  E. coli O157:H7 isolates in humans contain less stx1 than bovine strains, so maybe 
bovine have a greater influx of iron in general, possibly through feed.  Iron uptake could also 
have an inverse relationship with stx2.  Humans acquire higher amounts of stx2 and less stx1, 
suggesting humans do not have the required iron intake to activate the stx1 the same way as the 
bovine population. The possible lower concentration of iron in humans could, in return, account 
for the increased activation of stx2 that bovine do not have.   
Another area of interest for possible research could be Shiga toxin presence in old vs. 
young humans.  In Pruimboom-Brees study (2000) it was determined that calves had receptors as 
do humans whereas adult cattle contained an undetectable amount of receptors.   Calves vs. cattle 
could be a new insight to age being a factor of E. coli O157:H7-induced disease.  Determined, 
through multiple studies, HUS is caused by Shiga toxin production and is most common in small 
children.  Receptor studies in children verses the elder could be an area of growth in research.   
Growth in the area of research involving virulence factors should continue as only some 
questions have been answered and more questions are arising.  Linkages between the multiple 
factors and correlating them to disease and various strains, as in bovine and human, can 
eliminate bias in future studies. Focus on the effects of the virulent factor combinations instead 
of the effects of each separate factor may give more insight to how bovine strains are different 
than human strains of E. coli O157:H7.  For example, the study done by Boerlin et al. (1999) 
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confirmed that eae and stx2 did not only have a strong correlation to each other, but also 
possessed a higher frequency in human serotypes than in non-human serotypes and a higher 
frequency in diseased humans compared to non-diseased humans.  It can be purposed that the 
reaction between the two genes promotes a type of cascade reaction within the immune response 
system resulting in disease effects, such as HUS and HC.   Since bovine strains do not have the 
Gb3 receptor that is vital for stx2 to function, then perhaps reactions with eae are not possible 
and therefore omitting the pathogenic affects that are apparent in humans.   
Intimin is vital in producing Shiga toxin and disease in humans.  Perhaps further research 
in intimin subtypes verses E. coli serotypes could give clues as to why E. coli O157:H7 is more 
likely to produce disease when compared to other O157:H- isolates.  Another benefit to intimin 
research would be the ability to characterize E. coli strain serotypes based on the subtype of 
intimin it possesses.  One last aspect to research in this field is the ability to correlate initmin 
subtypes found in bovine verses initmin subtypes found in humans. This could be a potential 
factor in why cattle do not adhere Shiga toxin to the ER, but instead push it to lysosomes, which 
makes them asymptomatic to E. coli O157:H7 disease.     
 Locus of Enterocyte Effacement is largely responsible for encoding virulent factors that 
produce disease.  Future research regarding LEE effector molecules could potentially explain the 
difference of virulence between cattle and human reactions to E. coli O157:H7 presence.  EspD 
is significantly higher in humans along with stx2 and eae.  A combination of these three could 
explain the difference in pathogenic effects between cattle and human.  LEE houses critical 
factors involved in E. coli O157:H7-induced disease and could be the potential target for 
pathogenic differences between cattle and human populations. Factors that affect LEE induction 
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and the gene-encoding activity could be of interest as well since disease begins at the pathogenic 
island.   
 Attention to more specific biotechnology could help distinguish E. coli O157:H7 
strains from one another.  This in return could help increase monitoring and surveillance of 
different STEC strains as they transfer from cattle to human.  Knowledge of strains’ capabilities, 
in terms of transmission, could lead to better understanding of the pathogenic qualities that differ 
from serotype to serotype. 
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